What are the side effects of Enzalutamide?
Oct 21,2019
Enzalutamide is a type of hormone therapy for men with prostate cancer that has spread to other parts of the body (advanced prostate cancer) and has stopped responding to other types of hormone therapy.
It works by blocking the effect of the hormone testosterone on prostate cancer cells. Without testosterone, the prostate cancer cells can’t grow, even if they have spread to other parts of the body.Enzalutamide has been shown to help some men live longer. It can also help to treat or delay symptoms, such as pain and bone problems.
What are the side effects?
Notable side effects of enzalutamide seen in clinical trials have included gynecomastia, breast pain/tenderness, fatigue, diarrhea, hot flashes, headache, sexual dysfunction, and, less commonly, seizures. Other "common" side effects reported in clinical trials have included neutropenia, visual hallucinations, anxiety, cognitive disorder, memory impairment, hypertension, dry skin, and pruritus (itching). Enzalutamide monotherapy is regarded as having a moderate negative effect on sexual function and activity, significantly less than that of GnRH analogues but similar to that of other NSAAs such as bicalutamide.
Central adverse effects
Seizures have occurred in approximately 1% of patients treated with enzalutamide in clinical trials. This is thought to be due to enzalutamide crossing the blood–brain barrier and exerting off-target binding to and inhibition of the GABAA receptor in the central nervous system (it has been found to inhibit the GABAA receptor in vitro (IC50 = 3.6 μM) and induces convulsions in animals at high doses).
In addition to seizures, other potentially GABAA receptor-related side effects observed with enzalutamide treatment in clinical trials have included anxiety, insomnia, vertigo, paresthesia, and headache. Due to its ability to lower the seizure threshold, patients with known seizure disorders or brain injury should be closely monitored during enzalutamide treatment. NSAA-induced seizures are responsive to benzodiazepine treatment, and it has been suggested that GABAA receptor inhibition by enzalutamide could be treated with these drugs.
Speak to your doctor or specialist nurse if you have any side effects from taking enzalutamide, even if they’re not listed here. They may offer you other treatments to help manage any side effects.
- Related articles
- Related Qustion
- Enzalutamide: An Androgen Receptor Antagonist for Metastatic Castration-Resistant Prostate Cancer Feb 19, 2024
Enzalutamide offers significant benefits in treating metastatic CRPC with manageable safety concerns, necessitating diligent monitoring for optimal patient outcomes.
- Enzalutamide: A Review on its Applications in Cancer Apr 13, 2023
Enzalutamide is a second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer.
- MDV-3100 (Enzalutamide)- Pharmacodynamic Properties Dec 13, 2019
MDV3100, known as Enzalutamide, is a second-generation androgen receptor (AR) signaling inhibitor. It is able to inhibit binding of androgens to the AR, AR nuclear translocation, and the association of the AR with DNA.
Titanium nitride, abbreviated as TiN, is an extremely hard, synthetic ceramic material with hardness close to that of diamond.....
Oct 21,2019Inorganic saltsIn our first post about conditioning ingredients, we will tell you about the benefits of polyquaternium-10 (PQ10). PQ10 is basically cellulose that has been reacted a couple different ways.....
Oct 21,2019Catalyst and AuxiliaryEnzalutamide
915087-33-1You may like
- Enzalutamide
- $40.00 / 5mg
- 2024-11-18
- CAS:915087-33-1
- Min. Order:
- Purity: 99.67%
- Supply Ability: 10g
- Enzalutamide
- $0.00 / 1g
- 2024-11-18
- CAS:915087-33-1
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Enzalutamide
- $0.00 / 1Kg/Bag
- 2024-11-14
- CAS:915087-33-1
- Min. Order: 1KG
- Purity: 99.5%min
- Supply Ability: 100KGS